Company profile: SFC Fluidics
1.1 - Company Overview
Company description
- Provider of microfluidic-enabled medical devices, including the Gemini Dual Hormone Artificial Pancreas Pod, a wearable system delivering insulin and glucagon for diabetes management; the Panda Insulin Delivery Pod, a disposable subcutaneous insulin pump with precise dosing; and the Min-ePump, an implantable device for small animal research enabling remote-controlled, real-time drug dosing.
Products and services
- Gemini™ Dual Hormone Artificial Pancreas Pod (Gemini-DHAP): Wearable dual-hormone system engineered to deliver insulin and glucagon for diabetes management, actively modulating blood glucose levels using a pod
- Min-ePump™: Implantable drug delivery device engineered for small animal research, enabling remote-controlled, real-time dosing of drugs during experiments using a device platform
- Panda™ Insulin Delivery Pod: Disposable pump architected for subcutaneous insulin delivery, featuring microfluidic technology for precise dosing in a compact, single-use pod configuration
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to SFC Fluidics
Beta Bionics
HQ: United States
Website
- Description: Provider of software to reduce the burden of diabetes care, offering the iLet Bionic Pancreas, an insulin delivery system that autonomously manages and administers insulin doses based on continuous glucose monitoring data, with Dexcom G7 CGM integration for real-time dose adjustments and compatibility with prefilled insulin cartridges for convenience and choice among insulin types.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Beta Bionics company profile →
Intelligent Bio Solutions
HQ: United States
Website
- Description: Provider of diagnostic solutions, offering the Intelligent Fingerprinting Drug Screening System—a portable test that detects recent drug use via fingerprint sweat with results in under ten minutes—and a printable OTFT-based biosensor platform for real-time, non-invasive diagnostic tests adaptable to various health conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Intelligent Bio Solutions company profile →
Adocia
HQ: France
Website
- Description: Provider of biotechnology therapies specializing in tissue regeneration and diabetes treatments, developing medicines with already-approved therapeutic proteins. Offerings include BioChaperone Lispro ultra-rapid insulin, BioChaperone Combo glargine+lispro, AdoShell Islets hydrogel implant, M1Pram and BioChaperone LisPram co-formulations, and AdOral Sema oral semaglutide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adocia company profile →
JanOne
HQ: United States
Website
- Description: Provider of pharmaceutical drug candidates targeting severe pain conditions, including JAN101, a twice-daily slow-release oral sodium nitrite formulation for treatment and prevention of peripheral artery disease (PAD) and associated pain, and Jan123, a low-dose naltrexone candidate for complex regional pain syndrome delivered via a unique oral biphasic release tablet.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full JanOne company profile →
Medicore
HQ: United States
Website
- Description: Provider of blood collection and diabetic care products, manufacturing and distributing to hospitals and medical companies. Holds multiple contracts with hospital group purchasing organizations, with product line available through nearly all major medical device distributors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medicore company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for SFC Fluidics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to SFC Fluidics
2.2 - Growth funds investing in similar companies to SFC Fluidics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for SFC Fluidics
4.2 - Public trading comparable groups for SFC Fluidics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →